Who We Are-EN

Fundamental research and private companies together against COVID-19.

The MVM initiative originated in the international research project, The Global Argon Dark Matter Collaboration (GADM), which supports researchers looking for dark matter, an invisible component of the universe. This research includes experience with gas handling systems and complex control systems – the same capabilities required in hospital ventilators.

While in lockdown for the Covid-19 virus in Milan, Italy, Cristiano Galbiati, the spokesperson for the GADM Collaboration, recognized the need for additional ventilators early in the pandemic, and received government permission to develop a first prototype at the SAPIO Life s.r.l. ventilator repair and support center in Vaprio d’Adda, near Bergamo. With support from Italy’s National Institute for Nuclear Physics (INFN) and groups from the Universities of Milano Statale, Milano Bicocca, Napoli Federico II and Gran Sasso Science Institute (GSSI), and Elemaster S.p.A., AZ Pneumatica s.r.l., Saturn Magnetic s.r.l., Bel Power Europe s.r.l., and Nuclear Instruments s.r.l., they developed a first industrialized prototype, which fully demonstrated the viability of the conceptual design.
The collaboration expanded rapidly to include three national laboratories in Canada, including Canadian Nuclear Laboratories (CNL), TRIUMF and SNOLAB, through the leadership of Nobel laureate Dr. Art McDonald of Queen’s University. The US Collaboration includes people from Fermilab and the Princeton Plasma Physics Laboratory, two of the Department of Energy’s national laboratories as well as staff from US universities. The European collaboration also includes people from CNRS-IN2P3 and CIEMAT.

Getting the MVM ventilator to patients requires collaboration beyond nuclear and particle physicists. Government regulators, manufacturers and health care providers are also involved in the project.
To ensure the viability of the design in medical environments, clinical requirements are being developed with clinicians in the United States and Canada. Detailed testing and qualification of performance of the first prototype is underway with a breathing simulator at Ospedale San Gerardo in Monza, Italy and the Medicine Department of Milano Bicocca University.
The MVM Collaboration is being enthusiastically supported by industry members who are assessing part availability, evaluating supply chains, and who will eventually carry out the mass manufacturing. This process is already being supported by Elemaster in Italy. Canadian and American companies have been contacted to encourage their participation.
To facilitate rapid certification of the final design, additional direction is being provided by Health Canada, the US Air Force, the US FDA, and the Italian Istituto Superiore di Sanità and Consiglio Tecnico Scientifico della Protezione Civile.

The list of all MVM contributors and partners

A. Abba 36, P. Agnes 61, E. Alessi 23, P. Amaudruz 7, A. Annovi 30, M. Arba 26, F. Ardellier-Desages 10, C. Badia 22, J. Bagger 7,4, G. Batignani 30,47, G. Bellani 42, M. Beschi 19,39, G. Bianchi 39, D. Bishop 7, T. Boccali 30, V. Bocci 31, A. Bombarda 45, S. Bonfanti 45, W. Bonivento 26, B. Bottino 27, M. Bouchard 2, S. Brice 57, G. Buccino 22,53, S. Bussino 32, A. Caminata 27, A. Capra 7, M. Caravati 26, M. Carlini 22,53, L. Carrozzi 47, A. Ceccanti 24, J. M. Cela Ruiz 50, B. Celano 29, C. Charette 2, V. Cocco 26, S. Coelli 28, M. Constable 7, G. Croci 42, S. Cudmore 2, S. D’Auria 28, A. Dal Molin 42, G. Davenio 33, O. Davignon 11, S. De Cecco 31, L. De Laurentis 44, M. Del Tutto 57, J. deRuiter 2, A. Devoto 26, P. Diaz Gomez Maqueo 2, T. Dinon 39, E. Druszkiewicz 59, C. Duma 24, A. Fabbri 32, D. Farina 23, F. Ferroni 31, G. Fiorillo 29,43, R. Ford 6, G. Foti 42, D. Franco 10, F. Gabriele 34, C. Galbiati 58,35,22,26, P. Garcia Abia 50, A. Gargantini 45, L. Giacomelli 23, L. Giarratana 37, J. Givoletti 18, F. Golf 63, G. Gorini 42, E. Gramellini 57, G. Grosso 23, F. Guescini 15, E. Guetre 7, G. Hackman 7,4, T. Hadden 2, J. Hall 6, K. Hayashi 7,4, A. Heavey 57, J. Herperger 8, G. Hersak 2, N. Hessey 7, An. Ianni 58, C. Ienzi 2, V. Ippolito 31, C. Jillings 6,4, C. Kendziora 57, M. King 2, A. Kittmer 2, I. Kochanek 34, R. Kruecken 7, M. Kushoro 42, M. La Commara 29, G. Leblond 2, X. Li 58, C. Lim 7, T. Lindner 7, T. Lombardi 44, T. Long 2, S. Longo 24, P. Lu 7, G. A. Lukhanin 57, G. Magni 20, R. Maharaj 7, M. Malosio 39, C. Mapelli 38, P. Margetak 7, S. M. Mari 32, L. Martin 7, A. McDonald 5,4, D. Minuzzo 16, T. Mohayai 57, L. Molinari Tosatti 39, C. Moretti 48, A. Muraro 23, F. Nati 42, T. Noble 4,5, A. Norrick 57, K. Olchanski 7, F. Padula 1, I. Palumbo 17, E. Panontin 42, R. Paoletti 30,47, N. Paoli 18, S. Parmeggiano 40, L. Parmeggiano 40, C. Pearson 7, C. Pellegrino 24, P. Pelliccione 44,52, V. Pesudo 50,51, A. Pocar 62, M. Pontesilli 21, R. Pordes 57, S. Pordes 57, A. Prini 39, O. Putignano 42, J. Raaf 57, M. Razeti 26, A. Razeto 34, D. Reed 56, A. Renshaw 61, M. Rescigno 31, F. Retriere 7, E. Riccobene 46, D. Rigamonti 23, L. Rignanese 25, A. Rizzi 30,47, J. Rode 10,12, J. Romualdez 58,9, D. Sablone 34, D. Salomoni 24, R. Santorelli 50, E. Scapparone 25, T. Schaubel 2, M. Settimo 14, B. Shaw 7, B. Slutsky 9, B. Smith 7, N. Smith 6, P. Spagnolo 30, F. Spinella 30, A. Stenzler 54, A. Steri 26, L. Stiaccini 41,30, C. Stoughton 57, P. Stringari 13, M. Tardocchi 23, R. Tartaglia 34, G. Testera 27, E. Thomas 4, C. Tintori 18, J. Tseng 65, S. Viel 3, E. Viscione 28, A. Visioli 19,39, F. Vivaldi 18, J. Vossebeld 64, M. Wada 49, H. Wang 60, M. Wang 57, S. Westerdale 26, S. Yue 2, A. Zardoni 16, M. Zhang 55

Australia
Curtin University, Perth (1)

Canada
Canadian Nuclear Laboratories, Chalk River (2)
Carleton University, Ottawa (3)
McDonald Institute, (4)
Queen’s University, Kingston (5)
Sudbury Neutrino Observatory Laboratory, Creighton Mine (6)
TRIUMF: Canada’s particle accelerator centre, Vancouver (7)
The Mosaic Company, Regina (8)
University of Toronto, Toronto (9)

France
APC, CNRS/IN2P3, Université de Paris, Paris (10)
LLR, CNRS/IN2P3, École Polytechnique, Palaiseau (11)
LPNHE, CNRS/IN2P3, Sorbonne Université, Paris (12)
MINES ParisTech, Paris (13)
SUBATECH, CNRS/IN2P3, IMT-Atlantique, Université de Nantes, Nantes (14)

Germany
Max-Planck-Institut für Physik, Munich (15)

Italy
AZ Pneumatica S.R.L., Misinto (16)
Azienda Ospedaliera San Gerardo, Milano (17)
CAEN S.p.A., Viareggio (18)
Dipartimento di Meccanica e Ingegneria Industriale dell’Università degli Studi di Brescia, Brescia (19)
Elemaster Group S.p.A., Lomagna (20)
Ginevri S.R.L., Roma (21)
Gran Sasso Science Institute, L’Aquila (22)
ISTP – CNR, Milano (23)
Istituto Nazione di Fisica Nucleare – CNAF, Bologna (24)
Istituto Nazione di Fisica Nucleare – Sez. di Bologna, Bologna (25)
Istituto Nazione di Fisica Nucleare – Sez. di Cagliari, Cagliari (26)
Istituto Nazione di Fisica Nucleare – Sez. di Genova, Genova (27)
Istituto Nazione di Fisica Nucleare – Sez. di Milano, Milano (28)
Istituto Nazione di Fisica Nucleare – Sez. di Napoli, Napoli (29)
Istituto Nazione di Fisica Nucleare – Sez. di Pisa, Pisa (30)
Istituto Nazione di Fisica Nucleare – Sez. di Roma 1, Roma (31)
Istituto Nazione di Fisica Nucleare – Sez. di Roma 3, Roma (32)
Istituto Superiore di Sanità, Roma (33)
Laboratori Nazionali del Gran Sasso, Assergi (34)
Museo della fisica e Centro studi e Ricerche Enrico Fermi, Roma (35)
Nuclear Instruments S.R.L., Lambrugo (36)
Policlinico San Pietro, Ponte San Pietro (37)
Politecnico di Milano, Milano (38)
STIIMA – CNR, Milano (39)
Sergio Installazioni Snc, Treviglio (40)
Universit`a degli Studi di Siena, Siena (41)
Università Milano Bicocca, Milano (42)
Università degli Studi Federico II, Napoli (43)
Università degli Studi dell’Aquila, L’Aquila (44)
Università degli Studi di Bergamo, Bergamo (45)
Università degli Studi di Milano, Milano (46)
Università di Pisa, Pisa (47)
Università di Roma La Sapienza, Roma (48)

Poland
Particle Astrophysics Science and Technology Centre (AstroCeNT), Warsaw (49)

Spain
Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Madrid (50)
Laboratorio Subterráneo de Canfranc, Canfranc (51)

Sweden
Chalmers | University of Gothenburg, Gothenburg (52)

Switzerland
CERN (Conseil Européen pour la Recherche Nucléaire), Genève (53)

USA
12th Man Technologies, Inc., Garden Grove (54)
Department of Physics – University of Illinois, Champaign (55)
Equilbar L.L.C., Fletcher (56)
Fermilab National Laboratory, Batavia (57)
Princeton University, Princeton (58)
Rochester University, Rochester (59)
University of California Los Angeles, Los Angeles (60)
University of Houston, Houston (61)
University of Massachussets, Amherst (62)
University of Nebraska-Lincoln, Lincoln (63)

United Kingdom
Liverpool University, Liverpool (64)
University of Oxford, Oxford (65)